Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples